Higher expression of Axin2 in pancreatic adenocarcinomas and islet tumors compared to their non-neoplastic counterparts supports the potential importance of Wnt pathway activation in these tumors. This evidence concerns the gene AXIN2 and pancreatic adenocarcinoma.